JAJessica D. Austin

Jessica D. Austin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jessica D. Austin has a total of 158 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Lessons Learned From Implementing a Complex Cancer Symptom Monitoring Intervention With Electronic Patient Reported Outcome Measures, Electronic Clinician Decision Support, and Remote Collaborative Care Components

    by Sarah A. Minteer, Jennifer L. Ridgeway, Jessica D. Austin, Joan M. Griffin, Nathan K. Tesch, Amanda M. Nelson, Donna M. Dozois, Cindy Tofthagen, Sarah M. Burke, Robert R. McWilliams, et al.

  • Precision Cancer Prevention Needs Both Implementation Science and Ethics

    by Alexandra Wicker, Amanda Courtright-Lim, Lila J. Finney Rutten, Steven W. Ressler, Jon C. Tilburt, Jessica D. Austin

    As technological and genomic innovations continue to advance precision cancer prevention, psychosocial, ethical, and operational complexities increasingly accompany their development. Addressing these challenges will require intentional cross-disciplinary collaboration. We argue that the distinct yet complementary lenses of bioethics and implementation science will be crucial as precision cancer prevention technologies move toward clinical integration. We provide a framework for how this joint effort can be accomplished and sustained across the translational pipeline.

  • Perceptions of the Acceptability of Community-Based Breast Cancer Risk Assessment among Underserved Latinas in Maricopa County, Arizona

    by Jhenitza P. Raygoza, Jane Q. Yap, Valentina Hernandez, Crystal Gonzalez, Celine Vachon, Jessica D. Austin

    Latinas are more likely to be diagnosed with breast cancer at later stages than Non-Hispanic White women. Risk-based breast cancer screening offers a promising alternative to age-based approaches by prioritizing women at highest risk and reducing harms. Understanding the acceptability of a breast cancer risk assessment tool is essential for promoting uptake among Latinas. To explore the acceptability of performing a breast cancer risk assessment in community settings among Latinas residing in Maricopa County, Arizona. Twenty-three Latinas aged 45 to 65 years old, and residing in Maricopa County in Arizona, participated in focus groups and individual interviews between November 2022 and May 2023. Qualitative findings were analyzed by a deductive-inductive approach. Participants stated no experience using the risk assessment yet overwhelmingly expressed acceptability. Participants reported that early detection of breast cancer was a strong motivator but acknowledged how community acceptability would depend on the implementation of the tool. Latinas indicated that the tool would be best received if offered by word of mouth, social networks, and by aid of trusted health providers, including Community Health Workers. Latinas in Maricopa County portray an acceptability towards the risk assessment tool. Themes identified include the acceptability of breast cancer risk assessment and effective breast cancer risk assessment delivery in community settings. Potential strategies include using digital platforms (i.e., social media) and trusted health providers to disseminate the tool. Clinical Trial Registration: NCI202300465.

  • Open Access

    Underserved Latinas' Perceptions and Implications Around Breast Cancer Risk Assessment

    by Jane Q. Yap, Jhenitza P. Raygoza, Valentina Hernandez, Crystal Gonzalez, Celine Vachon, Jessica D. Austin

    Introduction: Breast cancer remains a leading cause of death among Latinas. Although breast cancer risk assessment models exist and show promise in reducing mortality, few studies have elicited women's interest in and perceptions around breast cancer risk assessment, particularly among underserved populations, like Latinas, who are susceptible to disparities in breast cancer outcomes. These disparities stem from factors such as limited access to healthcare services, lower rates of screening utilization, language barriers, and socioeconomic challenges, all of which compound their risk and hinder effective engagement with risk assessment tools. This qualitative study aims to explore Latinas' perspectives regarding breast cancer risk assessment and implications on future behaviors. Methods: Twenty‐three under‐ or uninsured Latinas aged 45–65 with no personal history of breast cancer took part in either a focus group ( n = 3, 15 participants) or individual interviews (8 participants). Guided by health behavior theories (Theory of Planned Behavior and Health Belief Model), data were transcribed, translated, and analyzed using a deductive‐inductive approach to thematic content analysis, resulting in four themes. Results: Latinas expressed high interest in knowing their breast cancer risk and reported that the benefits of knowing one's risk outweighed the harms. Latinas also stated that they would continue screening as recommended if found to be at low risk, but that they would speak with their provider or increase screening frequency if found to be at increased risk. Moreover, Latinas described the pivotal role of providers and social networks in influencing interest and perceptions around breast cancer risk assessment and preventive behaviors. Conclusion: Underserved Latinas viewed breast cancer risk assessment positively and underscored the need for multilevel, culturally tailored strategies to improve breast cancer risk assessment. This study yielded four distinct themes: (1) Interest and Awareness of Personal Breast Cancer Risk, (2) Benefits and Barriers of Knowing Personal Breast Cancer Risk, (3) Screening Implications of Knowing Personal Breast Cancer Risk, and (4) Provider Influence on Breast Cancer Risk Assessment and Behaviors. Potential strategies include efforts to improve provider engagement and communication and leveraging social networks to increase awareness and encourage preventive behaviors. Trial Registration: NCI‐2023‐00465

  • Sustainability of Complex Interventions: Recommendations from a Pragmatic Clinical Trial to Manage Cancer Symptoms.

    by Linda L Chlan, Jennifer L Ridgeway, Kathryn J Ruddy, Jessica D Austin, Sandra A Mitchell, Cindy Tofthagen, Deirdre R Pachman, Andrea L Cheville

    Sustained implementation of evidence-based practices and interventions in clinical settings is essential to ensure patients receive the best evidence-informed care. Information to guide sustainment of complex, multi-component interventions in routine clinical practice after grant funding ends has had limited attention in the literature.ObjectivesThe purpose of this article is to describe the efforts of our multidisciplinary trial team to foster sustainment of key components of a complex electronic health record (EHR)-facilitated symptom surveillance and management intervention for people receiving cancer care at a Midwestern quaternary medical center or community practice settings. The parent Enhanced EHR-facilitated Cancer Symptom Control (E2C2) hybrid type II effectiveness-implementation pragmatic trial assessed the effectiveness of a multi-component EHR-facilitated, collaborative care model-based intervention for management of SPPADE symptoms (Sleep interference, Pain, impaired Physical function, Anxiety, Depression, and Energy deficit/fatigue), and its implementation in medical oncology and community practice settings. The Dynamic Sustainability Framework (DSF) posits the need for on-going efforts to continuously optimize the fit of an intervention within dynamic and evolving delivery contexts. This Brief Report uses the DSF to describe our team's efforts to optimize the fit of the core E2C2 intervention components to the practice setting and broader ecological system during the conduct of the trial. These activities were designed to achieve sustained implementation of the intervention in routine care delivery as the funded research activities concluded. Core intervention components to be sustained were symptom surveillance using electronic patient-reported outcome measures, clinician alerts for severe symptoms, access to a registered nurse symptom care manager (RN SCM) for severe symptoms, patient education materials to support symptom self-management, access to a website of cancer-related materials, and the training and supervision of the RN SCMs. Sustainability is dynamic, multidimensional and emphasizes the importance of optimizing the fit of key intervention components to the care delivery context as it evolves time. Investigators are advised to plan sustainability efforts early, embrace change inherent in dynamic settings, and carefully track adaptations of intervention components to maximize intervention fit in real-world clinical practice to ensure patients continue to derive benefit from evidence-informed care.

  • Open Access

    Emerging concepts and practices in health disparities implementation science in the United States: a scoping review protocol

    by Dominique E Earland, Lynn J Andreae, Jessica D Austin, Sarah E Gollust, Sandra J Japuntich, Nicole Theis-Mahon, Erin Reardon, Kalthum Abdikeir, Ambria Crusan, Francine Overcash, et al.

    Introduction Implementation science research increases the uptake of evidence-based interventions, which may improve health equity among racial and ethnic minorities. However, it is unclear how anti-racism and anti-colonialism practices have been integrated into implementation science research. The objectives of this scoping review are to describe the current conceptualisations of racism and colonialism within the USA, examine racism or colonialism-conscious approaches and analyse gaps in the operationalisation of anti-racism or anti-colonialism within implementation science studies. Methods and analysis This scoping review will be conducted following the Preferred Reporting Items for Systematic Reviews and Meta-analyses extension for scoping reviews guidelines. The Center for Chronic Disease Reduction and Equity Promotion Across Minnesota conceptual framework and an implementation science anti-racism lens will guide the study design and analysis. To determine study eligibility for the scoping review, articles will undergo abstract and full-text screening by two independent reviewers and discrepancies will be settled together. Data charting will be extracted from included articles by eight independent reviewers. The search strategy will use controlled vocabulary and natural language keywords related to health equity, health disparities and anti-racism/colonialism on six databases. The scoping review will include studies that applied implementation science theories, models or frameworks among US-based populations. Additionally, included studies will report any of the following implementation activities: implementation strategies, implementation outcomes, adaptations to evidence-based interventions, or evaluations of pre-implementation or implementation context. Ethics and dissemination No ethical approval was required for the scoping review. Dissemination will be through publication in a peer-reviewed journal and conference presentations.


  • Open Access

    Primary Care Clinician Preferences and Perspectives on Multi-Cancer Detection Testing Across an Integrated Healthcare System

    by Jessica D. Austin, Ilyse A. Nelson, Jon C. Tilburt, Eric R. Ellinghysen, Claire Yee, Jaxon Quillen, Brian M. Dougan, John R. Presutti, Ryan T. Hurt, Niloy Jewel Samadder, et al.

    Background/Objectives: Multi-cancer detection (MCD) tests have emerged as a promising tool to redefine the landscape of early cancer detection. Implementation of this novel technology will likely fall to primary care clinicians (PCC). The purpose of this study is to characterize and explore differences in PCCs perceptions and preferences towards MCD testing. Methods: Between March and May of 2023, this cross-sectional survey was administered to 281 PCCs, including physicians and advanced care providers practicing within an integrated healthcare system spanning five states. The survey collected data on self-reported characteristics, perceptions of MCD testing, and preferences for learning about MCD testing. Analysis was limited to those with no prior experience with MCD testing (N = 181, response rate 22.8%). Descriptive statistics summarized key variables and chi-square tests assessed differences in perceptions and preferences by key characteristics. Results: Most PCCs were interested in MCD testing (66.3%), but limited knowledge/awareness of MCD testing and confidence to manage patients with a positive test were observed, along with concerns around cost (76.7%) and misuse/poor implementation. The primary preferences for learning about MCD testing were online courses or classroom instruction (64.5%). Significant differences in perceptions and preferences for learning were observed by location, degree, and years in practice. Conclusions: PCCs in our study held positive views towards MCD testing, but gaps and variation in knowledge and confidence towards MCD testing and concerns around the cost and misuse/poor implementation were observed. While efforts to train and educate all PCCs on MCD testing is a critical first step, more research is needed to understand how best to support implementation tailored to individual and system-level needs and characteristics.


  • Open Access

    Enhancing cognitive function in breast cancer survivors through community-based aerobic exercise training: protocol for a Hybrid Type I effectiveness–implementation study employing a randomised controlled design

    by Diane K Ehlers, Jessica D Austin, Brenda Ernst, Lindsey L Page, Edward Ofori, Gwenndolyn C Porter, Jason Fanning, Gabriella Hickman, Paul McKim, Melissa Cole, et al.

    Introduction: Despite growing evidence to characterise cancer-associated cognitive decline (CACD) in women with breast cancer, interventions to mitigate CACD are limited. Emerging evidence suggests aerobic exercise may enhance cognition after breast cancer diagnosis and treatment; yet, CACD remains an understudied outcome of exercise, and few high-quality studies have been conducted. In addition to knowledge gaps in effectiveness, the translation of exercise interventions to community settings remains challenging. The Breast cancer Reasoning and Activity INtervention (BRAIN) investigates the effectiveness of aerobic exercise training, delivered in a community-based setting, for improving cognitive function in women with breast cancer and gathers information on the implementation success of the intervention. Methods and analysis: This Hybrid Type I effectiveness–implementation study is conducted at an academic medical centre in the southwestern United States in partnership with a non-profit, community health and wellness organisation. The study enrols 160 women diagnosed with stage I–IIIa breast cancer and within 3–36 months of treatment completion into a 1:1 randomised controlled trial. Individuals randomised to the exercise group receive a 6-month, individually tailored aerobic exercise programme delivered by exercise trainers employed at local community fitness centres. The programme is progressive in nature and designed to help participants achieve aerobic exercise levels consistent with guidelines for cancer survivors. Individuals randomise to the control group receive a 6-month health education control intervention delivered virtually by hospital-based health educators. Cognitive performance (primary), self-reported cognition, patient-reported outcomes, physical activity and cardiorespiratory fitness are measured at baseline, 6 months (postintervention) and 12 months (follow-up). Brain structure and function are measured via magnetic resonance imaging (MRI) at baseline and 6 months. Implementation outcomes are defined by the RE-AIM framework, which includes reach, effectiveness, adoption, implementation and maintenance. RE-AIM outcomes are measured at baseline, 6 months, 12 months and ongoing during the study. Ethics and dissemination: This study was approved by the Mayo Clinic Institutional Review Board (#23-000020). All participants provide informed consent prior to participation. Findings will be disseminated to scientific, clinical and community audiences through manuscripts, presentations and newsletters. Trial registration number: NCT04816006.


  • Open Access

    Effectiveness of Breast Density Educational Interventions on Mammography Screening Adherence Among Underserved Latinas: A Randomized Controlled Trial

    by Jessica D. Austin, Sarah M. Jenkins, Vera J. Suman, Jennifer L. Ridgeway, Bhavika K. Patel, Karthik Ghosh, Deborah J. Rhodes, Bijan J. Borah, Aaron D. Norman, Edna P. Ramos, et al.

    Background: Latinas with mammographic dense breasts are at increased risk of breast cancer. This randomized controlled trial tests the effectiveness of three breast density (BD) educational approaches on adherence to subsequent mammography screening among Latinas receiving care at a Federally Qualified Health Center (FQHC). Measure(s): Adherence was ascertained using electronic health record and survey responses. Kaplan–Meier estimates of the time to subsequent mammogram were used to obtain adherence rates at 1- and 2-years post baseline mammogram. Cox modeling assessed whether adherence differed by patient characteristics or group assignment. Results: This analysis was limited to Latinas enrolled between October 27, 2016, and December 21, 2018 ( n = 946; 66.1% p = 0.76) . Adjusting for age and study group, having more prior mammograms, being “extremely likely” to get an annual mammogram, and having more confidence to get an annual mammogram at baseline were significant drivers of subsequent adherence. Conclusion: Informational interventions targeting BD education alone are unlikely to significantly improve adherence to subsequent mammography among Latinas receiving care in FQHCs.


  • Open Access

    Advancing Care Team Adoption of Electronic Health Record Systems for Cancer Symptom Management: Findings From a Hybrid Type II, Cluster-Randomized, Stepped-Wedge Trial

    by Jessica D. Austin, Lila J. Finney Rutten, Kristin Fischer, Jennifer Ridgeway, Sarah Minteer, Joan M. Griffin, Deirdre R. Pachman, Kathryn J. Ruddy, Andrea Cheville

    PURPOSE: The enhanced, electronic health record (EHR)–facilitated cancer symptom control (E2C2) trial is a cohort cluster-randomized, stepped-wedge, hybrid type II trial that leverages EHR systems to facilitate a collaborative care model (CCM) approach with the goal of improving cancer symptom management. Understanding factors that influence care team adoption of EHR systems remains a critical understudied area of research. This study examines how oncology care teams' perceptions regarding the feasibility, acceptability, and appropriateness of E2C2 EHR systems preimplementation were associated with adoption 3 months after implementation and characterizes differences in adoption by individual- and system-level factors. METHODS: Care team members completed an electronic survey before and 3 months after implementation of E2C2 for their respective sequence. Adoption was defined as frequency of use to statements aligned with care team–directed EHR systems designed to facilitate CCM approaches. Chi-square tests assessed differences in adoption while logistic regression models estimated associations between baseline mean scores of acceptability, feasibility, and appropriateness on care team adoption at 3 months. RESULTS: Results from 94 care team members (37.2% oncologists, 72.6% female, 55.3% in their role for 6+ years) found that adoption rates ranged from 48.9% to 71.7%, with significant differences observed by location (community-based health care systems v tertiary medical center) and professional role. Adjusting for professional role, care team members reporting higher levels of perceived acceptability and appropriateness at baseline had greater odds of adopting EHR systems at 3 months. CONCLUSION: EHR systems perceived as acceptable and appropriate are more likely to be adopted by oncology care teams in our sample. Future implementation efforts should consider tailored strategies to facilitate adoption of EHR systems designed to promote CCM-based approaches to improve cancer symptom management.